Patents Assigned to Ben Gurion University
  • Patent number: 8594998
    Abstract: The invention relates to a multilingual method for summarizing an article, which comprises an offline stage in which a weights vector is determined using, among others, plurality of predefined metrics, a collection of documents and expert prepared summaries, subjection of all the document sentences to all said metrics, guess of a population of weights matrices, subjection of the population to said metrics, ranking of sentences, generation of a new population using a genetic algorithm, and repetition of the same until convergence. The invention further comprises a real time stage in which the weights vector, as determined, as well as said metrics are used to determine an extract of any new document.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: November 26, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Marina Litvak, Mark Last, Menahem Friedman
  • Publication number: 20130292252
    Abstract: The present invention provides anion exchange membranes, processes for producing same and uses thereof. The anion exchange membranes according to embodiments of the present invention achieve a desirable combination of low resistance, high permselectivity and low degree of dimensional swelling. Anion exchange membranes according to embodiments of the present invention are also cost effective.
    Type: Application
    Filed: December 12, 2011
    Publication date: November 7, 2013
    Applicant: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Charles Linder, Ora Kedem, Rami Messalem
  • Patent number: 8575093
    Abstract: A method of preventing and/or treating S. pneumoniae infection in mammalian subjects, wherein said method comprises administering to said subjects a composition comprising one or more agents that are capable of inhibiting the binding of the S. pneumoniae cell wall protein FBA to the respiratory tract cells of said subject.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: November 5, 2013
    Assignees: Ben-Gurion University of the Negev Research and Development Authority, Mor Research Applications Ltd.
    Inventors: Yaffa Mizrachi Nebenzahl, Ron Dagan
  • Patent number: 8547236
    Abstract: Apparatus for detection of human falls comprises: an acceleration detector, for detecting vibration events, typically placed on a floor, a microphone, located in association with the acceleration detector for detection of corresponding sound events, and a classification unit to classify concurrent events from the microphone and the acceleration detector, thereby to determine whether a human fall is indicated. If the event appears to be a human fall, then an alarm is raised.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: October 1, 2013
    Assignees: Ramot at Tel-Aviv University Ltd., Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Israel Gannot, Dimitry Litvak, Yaniv Zigel
  • Publication number: 20130251685
    Abstract: A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following deposition within the body tissue. The therapeutic composition can be effectively administered into a damaged body tissue via injection or catheterization, thereby treating the damaged body tissue.
    Type: Application
    Filed: May 1, 2013
    Publication date: September 26, 2013
    Applicant: Ben-Gurion University of the Negev
    Inventors: Smadar Cohen, Jonathan Leor
  • Patent number: 8531873
    Abstract: An SRAM memory cell with an internal supply feedback loop is provided herein. The memory cell includes a latch that has a storage node Q, a storage node QB, a supply node, and a ground node. The supply node is coupled via a gating device to a supply voltage and ground node is connected to ground. In addition, storage node Q is fed back via feedback loop into a control node of the gating device. In operation, writing into the memory cell may be carried out in a similar manner to dual port SRAM cells, utilizing one or two write circuitries and for writing into storage node Q and storage node QB respectively. Differently from standard SRAM cells, the feedback loop, by controlling the gating device is configured to weaken the write contention.
    Type: Grant
    Filed: May 8, 2011
    Date of Patent: September 10, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Adam Teman, Lidor Pergament, Omer Cohen, Alexander Fish
  • Patent number: 8513151
    Abstract: Sulfur chelated ruthenium compounds represented by the following formula: wherein M indicates the ruthenium metal bound to a benzylidene carbon; R represents C1-C7 alkyl group or optionally substituted aryl; X1 and X2 each independently represent halogen; Y1 and Y2 each independently denote unsubstituted or alkyl-substituted phenyl; and Z independently represents hydrogen, electron withdrawing or electron donating substituent, with m being an integer from 1 to 4, and processes and compositions related thereto.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: August 20, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Gabriel N. Lemcoff, Amos Ben-Asuly
  • Patent number: 8513437
    Abstract: The invention provides pyrrolidino-substituted 1,4-naphthoquinone derivatives that modulate the activity of protein kinases, and it relates to the use of the derivatives in pharmaceutical compositions for treating cardiovascular disorders and malignancies. The invention particularly provides medicaments for treating disorders associated with MAPKs signaling, ERKs signaling, p38 signaling, and JNKs signaling.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: August 20, 2013
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Yossi Granot, Shmuel Bittner
  • Publication number: 20130189704
    Abstract: This invention is directed, inter alia, to methods and kits for rapid, easy and cost-effective methods of breast cancer prediction and diagnosis in inter alia, blood samples.
    Type: Application
    Filed: October 24, 2012
    Publication date: July 25, 2013
    Applicants: Mor Research Application Ltd., Ben Gurion University of the Negev Research and Development Authority
    Inventors: Ben Gurion University of the Negev Research and, Mor Research Application Ltd.
  • Patent number: 8492050
    Abstract: A polymer electrolyte membrane (PEM) for fuel cells is provided, as well as a method for manufacturing the PEM by direct casting on the fuel cells electrodes. The PEM, consisting of an ionic liquid entrapped within polysiloxane-RTV matrix, is stable at high temperatures, in acidic and basic environments, and exhibits a high conductivity, without the crossover of methanol.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: July 23, 2013
    Assignee: Ben Gurion University of the Negev Research & Development Authority
    Inventors: Eli Korin, Armand Bettelheim
  • Patent number: 8470409
    Abstract: A method of forming a nanowire structure is disclosed. The method comprises applying on a surface of carrier liquid a layer of a liquid composition which comprises a surfactant and a plurality of nanostructures each having a core and a shell, and heating at least one of the carrier liquid and the liquid composition to a temperature selected such that the nanostructures are segregated from the surfactant and assemble into a nanowire structure on the surface.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: June 25, 2013
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Roman Volinsky, Raz Jelinek
  • Patent number: 8461132
    Abstract: A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following deposition within the body tissue. The therapeutic composition can be effectively administered into a damaged body tissue via injection or catheterization, thereby treating the damaged body tissue.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: June 11, 2013
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Smadar Cohen, Jonathan Leor
  • Patent number: 8455463
    Abstract: A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following deposition within the body tissue. The therapeutic composition can be effectively administered into a damaged body tissue via injection or catheterization, thereby treating the damaged body tissue.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: June 4, 2013
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Smadar Cohen, Jonathan Leor
  • Patent number: 8455557
    Abstract: There are provided herein selective membranes, such as composite membranes, and/or films and processes for their preparation. The membranes and/or films have a given morphology which may be stabilized, for example against swelling and chemical degradation, by covalent crosslinking and optionally, in addition, by hydrophobization. There is provided a membrane and/or film and a process for the preparation thereof, the membrane and/or film include an ionomer and/or polyelectrolyte crosslinked through aryl-aryl (—Ar—Ar—), aryl-ether-aryl (—Ar—O—Ar—) and/or aryl-sulfide-aryl (—Ar—S—Ar—) bonds.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: June 4, 2013
    Assignee: Ben Gurion University of the Negev R&D Authority
    Inventors: Charles Linder, Ora Kedem, Yoram Oren
  • Publication number: 20130128904
    Abstract: The invention is an apparatus and method for free space pumping of active double-clad fiber based lasers and amplifiers. The apparatus comprises a laser emitting a signal laser beam; an active double-clad fiber having a core defining an optical axis of the apparatus and a pump cladding defining a cone of numerical aperture; an optical arrangement directing the signal laser beam along the optical axis through the core of the active double-clad fiber; at least one pump source emitting a pump beam; at least one delivery means coupling the pump beam to the pump cladding of the active double-clad fiber; and an optical arrangement coupling the amplified signal laser beam exiting the active double-clad fiber out of the apparatus.
    Type: Application
    Filed: July 30, 2010
    Publication date: May 23, 2013
    Applicant: Ben-Gurion University of The Negev Research and De Authority
    Inventors: Amiel Ishaaya, Boris Shulga
  • Publication number: 20130122117
    Abstract: Provided is a formulation containing amorphous or microcrystalline calcium carbonate finely interspersed with organic matter in a ratio of 10 parts of the carbonate per 1 to 3 parts of the organic matter, wherein the organic matter consists of chitin and polypeptide. The formulation is efficient in treating various pathological conditions, including proliferative diseases, neurological disorders, and musculoskeletal disorders.
    Type: Application
    Filed: December 27, 2012
    Publication date: May 16, 2013
    Applicants: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Ben-Gurion University of the Negev Research and Development Authority, Yossi Ben
  • Patent number: 8440878
    Abstract: The present invention relates to a nucleic acid molecule encoding an insulin-like factor of the androgenic gland of the freshwater prawn Macrobrachium rosenbergii (M. rosenbergii). The present invention further relates to methods of silencing the expression of the insulin-like factor gene in decapod crustaceans order, particularly in M. rosenbergii, useful for producing male monosex populations.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: May 14, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Amir Sagi, Tomer Ventura
  • Patent number: 8440788
    Abstract: The present invention relates generally to variants and peptides of the mitochondrial protein, voltage-dependent anion channel (VDAC) and to polynucleotides encoding same. In particular, the present invention is directed to N-terminal truncated and mutated VDAC and specific amino acid and polynucleotide sequences thereof useful in inhibiting apoptosis, and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with excess apoptosis.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: May 14, 2013
    Assignee: Ben-Gurion University of The Negev Research and Development Authority Ltd.
    Inventors: Varda Shoshan-Barmatz, Doron Calo
  • Publication number: 20130109615
    Abstract: A method of treating a patient suffering from a disease characterized by tissue necrosis by administering to the patient a necrosis inhibitor and/or a Humanin or a derivative of Humanin is provided. The invention further includes a method for prophylactically treating a patient at risk for a pathological condition that is precipitated at least in part by tissue necrosis by administering to the patient a necrosis inhibitor and/or a Humanin or a derivative of Humanin.
    Type: Application
    Filed: February 23, 2011
    Publication date: May 2, 2013
    Applicant: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Abraham Parola, Ilana Nathan, Ron Kasher, Jenny Lerner Yardeni, Aviv Cohen
  • Publication number: 20130108659
    Abstract: Vaccine compositions and methods for protecting a mammalian subject against infection with S. pneumoniae are disclosed. The vaccines and methods comprise an effective amount of one or more Streptococcus pneumoniae cell wall and/or cell membrane proteins and/or immunogenically-active fragments, derivatives or modifications thereof, wherein the proteins are selected from a defined group of proteins associated with age-dependent immunological responses.
    Type: Application
    Filed: January 4, 2013
    Publication date: May 2, 2013
    Applicant: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Ben-Gurion University of the Negev Research and Development Authority